Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Feb;34(2):183–188. doi: 10.1128/aac.34.2.183

Amphotericin B: current understanding of mechanisms of action.

J Brajtburg 1, W G Powderly 1, G S Kobayashi 1, G Medoff 1
PMCID: PMC171553  PMID: 2183713

Full text

PDF
183

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Athar M. A., Winner H. I. The development of resistance by candida species to polyene antibiotics in vitro. J Med Microbiol. 1971 Nov;4(4):505–517. doi: 10.1099/00222615-4-4-505. [DOI] [PubMed] [Google Scholar]
  2. Bagiński M., Tempczyk A., Borowski E. Comparative conformational analysis of cholesterol and ergosterol by molecular mechanics. Eur Biophys J. 1989;17(3):159–166. doi: 10.1007/BF00254770. [DOI] [PubMed] [Google Scholar]
  3. Bennett J. E., Dismukes W. E., Duma R. J., Medoff G., Sande M. A., Gallis H., Leonard J., Fields B. T., Bradshaw M., Haywood H. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med. 1979 Jul 19;301(3):126–131. doi: 10.1056/NEJM197907193010303. [DOI] [PubMed] [Google Scholar]
  4. Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys Acta. 1986 Dec 22;864(3-4):257–304. doi: 10.1016/0304-4157(86)90002-x. [DOI] [PubMed] [Google Scholar]
  5. Bonner D. P., Tewari R. P., Solotorovsky M., Mechlinski W., Schaffner C. P. Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester. Antimicrob Agents Chemother. 1975 Jun;7(6):724–729. doi: 10.1128/aac.7.6.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brajtburg J., Elberg S., Kobayashi G. S., Medoff G. Effects of ascorbic acid on the antifungal action of amphotericin B. J Antimicrob Chemother. 1989 Sep;24(3):333–337. doi: 10.1093/jac/24.3.333. [DOI] [PubMed] [Google Scholar]
  7. Brajtburg J., Elberg S., Kobayashi G. S., Medoff G. Toxicity and induction of resistance to Listeria monocytogenes infection by amphotericin B in inbred strains of mice. Infect Immun. 1986 Nov;54(2):303–307. doi: 10.1128/iai.54.2.303-307.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brajtburg J., Elberg S., Medoff J., Kobayashi G. S., Schlessinger D., Medoff G. Stimulatory, permeabilizing, and toxic effects of amphotericin B on L cells. Antimicrob Agents Chemother. 1984 Dec;26(6):892–897. doi: 10.1128/aac.26.6.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brajtburg J., Elberg S., Schwartz D. R., Vertut-Croquin A., Schlessinger D., Kobayashi G. S., Medoff G. Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B. Antimicrob Agents Chemother. 1985 Feb;27(2):172–176. doi: 10.1128/aac.27.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brajtburg J., Powderly W. G., Kobayashi G. S., Medoff G. Amphotericin B: delivery systems. Antimicrob Agents Chemother. 1990 Mar;34(3):381–384. doi: 10.1128/aac.34.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brezis M., Rosen S., Silva P., Spokes K., Epstein F. H. Polyene toxicity in renal medulla: injury mediated by transport activity. Science. 1984 Apr 6;224(4644):66–68. doi: 10.1126/science.6322305. [DOI] [PubMed] [Google Scholar]
  12. Capuozzo E., Bolard J. Interaction of the polyene antibiotic etruscomycin with large unilamellar lipid vesicles: binding and proton permeability inducement. Biochim Biophys Acta. 1985 Oct 24;820(1):63–73. doi: 10.1016/0005-2736(85)90216-0. [DOI] [PubMed] [Google Scholar]
  13. Chéron M., Cybulska B., Mazerski J., Grzybowska J., Czerwiński A., Borowski E. Quantitative structure-activity relationships in amphotericin B derivatives. Biochem Pharmacol. 1988 Mar 1;37(5):827–836. doi: 10.1016/0006-2952(88)90168-2. [DOI] [PubMed] [Google Scholar]
  14. Cybulska B., Herve M., Borowski E., Gary-Bobo C. M. Effect of the polar head structure of polyene macrolide antifungal antibiotics on the mode of permeabilization of ergosterol- and cholesterol-containing lipidic vesicles studied by 31P-NMR. Mol Pharmacol. 1986 Mar;29(3):293–298. [PubMed] [Google Scholar]
  15. Cybulska B., Mazerski J., Borowski E., Gary-Bobo C. M. Haemolytic activity of aromatic heptaenes. A group of polyene macrolide antifungal antibiotics. Biochem Pharmacol. 1984 Jan 1;33(1):41–46. doi: 10.1016/0006-2952(84)90368-x. [DOI] [PubMed] [Google Scholar]
  16. Dick J. D., Merz W. G., Saral R. Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother. 1980 Jul;18(1):158–163. doi: 10.1128/aac.18.1.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Dick J. D., Rosengard B. R., Merz W. G., Stuart R. K., Hutchins G. M., Saral R. Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii. Ann Intern Med. 1985 Jan;102(1):67–68. doi: 10.7326/0003-4819-102-1-67. [DOI] [PubMed] [Google Scholar]
  18. Dismukes W. E., Cloud G., Gallis H. A., Kerkering T. M., Medoff G., Craven P. C., Kaplowitz L. G., Fisher J. F., Gregg C. R., Bowles C. A. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med. 1987 Aug 6;317(6):334–341. doi: 10.1056/NEJM198708063170602. [DOI] [PubMed] [Google Scholar]
  19. Drutz D. J., Lehrer R. I. Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function. Am J Med Sci. 1978 Jul-Aug;276(1):77–92. [PubMed] [Google Scholar]
  20. Ellis W. G., Sobel R. A., Nielsen S. L. Leukoencephalopathy in patients treated with amphotericin B methyl ester. J Infect Dis. 1982 Aug;146(2):125–137. doi: 10.1093/infdis/146.2.125. [DOI] [PubMed] [Google Scholar]
  21. Gale E. F. Nature and development of phenotypic resistance to amphotericin B in Candida albicans. Adv Microb Physiol. 1986;27:277–320. doi: 10.1016/s0065-2911(08)60307-0. [DOI] [PubMed] [Google Scholar]
  22. Galgiani J. N. Antifungal susceptibility tests. Antimicrob Agents Chemother. 1987 Dec;31(12):1867–1870. doi: 10.1128/aac.31.12.1867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gresham H. D., McGarr J. A., Shackelford P. G., Brown E. J. Studies on the molecular mechanisms of human Fc receptor-mediated phagocytosis. Amplification of ingestion is dependent on the generation of reactive oxygen metabolites and is deficient in polymorphonuclear leukocytes from patients with chronic granulomatous disease. J Clin Invest. 1988 Oct;82(4):1192–1201. doi: 10.1172/JCI113716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gruda I., Nadeau P., Brajtburg J., Medoff G. Application of differential spectra in the ultraviolet-visible region to study the formation of amphotericin B-sterol complexes. Biochim Biophys Acta. 1980 Nov 4;602(2):260–268. doi: 10.1016/0005-2736(80)90309-0. [DOI] [PubMed] [Google Scholar]
  25. HEBEKA E. K., SOLOTOROVSKY M. DEVELOPMENT OF RESISTANCE TO POLYENE ANTIBIOTICS IN CANDIDA ALBICANS. J Bacteriol. 1965 Jun;89:1533–1539. doi: 10.1128/jb.89.6.1533-1539.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hamilton-Miller J. M. Sterols from polyene-resistant mutants of Candida albicans. J Gen Microbiol. 1972 Nov;73(1):201–203. doi: 10.1099/00221287-73-1-201. [DOI] [PubMed] [Google Scholar]
  27. Henry-Toulmé N., Seman M., Bolard J. Interaction of amphotericin B and its N-fructosyl derivative with murine thymocytes: a comparative study using fluorescent membrane probes. Biochim Biophys Acta. 1989 Jul 10;982(2):245–252. doi: 10.1016/0005-2736(89)90061-8. [DOI] [PubMed] [Google Scholar]
  28. Hitchcock C. A., Barrett-Bee K. J., Russell N. J. The lipid composition and permeability to azole of an azole- and polyene-resistant mutant of Candida albicans. J Med Vet Mycol. 1987 Feb;25(1):29–37. doi: 10.1080/02681218780000041. [DOI] [PubMed] [Google Scholar]
  29. Hoeprich P. D., Flynn N. M., Kawachi M. M., Lee K. K., Lawrence R. M., Heath L. K., Schaffner C. P. Treatment of fungal infections with semisynthetic derivatives of amphotericin B alpha. Ann N Y Acad Sci. 1988;544:517–546. doi: 10.1111/j.1749-6632.1988.tb40449.x. [DOI] [PubMed] [Google Scholar]
  30. Howarth W. R., Tewari R. P., Solotorovsky M. Comparative in vitro antifungal activity of amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother. 1975 Jan;7(1):58–63. doi: 10.1128/aac.7.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kiehn T. E., Nelson P. E., Bernard E. M., Edwards F. F., Koziner B., Armstrong D. Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma. J Clin Microbiol. 1985 Apr;21(4):501–504. doi: 10.1128/jcm.21.4.501-504.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kotler-Brajtburg J., Medoff G., Kobayashi G. S., Boggs S., Schlessinger D., Pandey R. C., Rinehart K. L., Jr Classification of polyene antibiotics according to chemical structure and biological effects. Antimicrob Agents Chemother. 1979 May;15(5):716–722. doi: 10.1128/aac.15.5.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lamy-Freund M. T., Ferreira V. F., Schreier S. Mechanism of inactivation of the polyene antibiotic amphotericin B. Evidence for radical formation in the process of autooxidation. J Antibiot (Tokyo) 1985 Jun;38(6):753–757. doi: 10.7164/antibiotics.38.753. [DOI] [PubMed] [Google Scholar]
  34. Lutwick L. I., Galgiani J. N., Johnson R. H., Stevens D. A. Visceral fungal infections due to Petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies. Am J Med. 1976 Nov;61(5):632–640. doi: 10.1016/0002-9343(76)90141-8. [DOI] [PubMed] [Google Scholar]
  35. Marcon M. J., Durrell D. E., Powell D. A., Buesching W. J. In vitro activity of systemic antifungal agents against Malassezia furfur. Antimicrob Agents Chemother. 1987 Jun;31(6):951–953. doi: 10.1128/aac.31.6.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Medoff G., Kobayashi G. S., Kwan C. N., Schlessinger D., Venkov P. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism). Proc Natl Acad Sci U S A. 1972 Jan;69(1):196–199. doi: 10.1073/pnas.69.1.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Merz W. G., Sandford G. R. Isolation and characterization of a polyene-resistant variant of Candida tropicalis. J Clin Microbiol. 1979 Jun;9(6):677–680. doi: 10.1128/jcm.9.6.677-680.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Milhaud J., Hartmann M. A., Bolard J. Interaction of the polyene antibiotic amphotericin B with model membranes: differences between small and large unilamellar vesicles. Biochimie. 1989 Jan;71(1):49–56. doi: 10.1016/0300-9084(89)90130-2. [DOI] [PubMed] [Google Scholar]
  39. Pappagianis D., Collins M. S., Hector R., Remington J. Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother. 1979 Aug;16(2):123–126. doi: 10.1128/aac.16.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Parmegiani R. M., Loebenberg D., Antonacci B., Yarosh-Tomaine T., Scupp R., Wright J. J., Chiu P. J., Miller G. H. Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B. Antimicrob Agents Chemother. 1987 Nov;31(11):1756–1760. doi: 10.1128/aac.31.11.1756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Pierce A. M., Pierce H. D., Jr, Unrau A. M., Oehlschlager A. C. Lipid composition and polyene antibiotic resistance of Candida albicans mutants. Can J Biochem. 1978 Feb;56(2):135–142. doi: 10.1139/o78-023. [DOI] [PubMed] [Google Scholar]
  42. Powderly W. G., Kobayashi G. S., Herzig G. P., Medoff G. Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med. 1988 May;84(5):826–832. doi: 10.1016/0002-9343(88)90059-9. [DOI] [PubMed] [Google Scholar]
  43. Saag M. S., Dismukes W. E. Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother. 1988 Jan;32(1):1–8. doi: 10.1128/aac.32.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sarthou P., Primi D., Cazenave P. A. B cell triggering properties of a nontoxic derivative of amphotericin B. J Immunol. 1986 Oct 1;137(7):2156–2161. [PubMed] [Google Scholar]
  45. Sokol-Anderson M. L., Brajtburg J., Medoff G. Amphotericin B-induced oxidative damage and killing of Candida albicans. J Infect Dis. 1986 Jul;154(1):76–83. doi: 10.1093/infdis/154.1.76. [DOI] [PubMed] [Google Scholar]
  46. Sokol-Anderson M. L., Brajtburg J., Medoff G. Sensitivity of Candida albicans to amphotericin B administered as single or fractionated doses. Antimicrob Agents Chemother. 1986 Apr;29(4):701–702. doi: 10.1128/aac.29.4.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sokol-Anderson M., Sligh J. E., Jr, Elberg S., Brajtburg J., Kobayashi G. S., Medoff G. Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B. Antimicrob Agents Chemother. 1988 May;32(5):702–705. doi: 10.1128/aac.32.5.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Stein S. H., Little J. R., Little K. D. Parallel inheritance of tissue catalase activity and immunostimulatory action of amphotericin B in inbred mouse strains. Cell Immunol. 1987 Mar;105(1):99–109. doi: 10.1016/0008-8749(87)90059-1. [DOI] [PubMed] [Google Scholar]
  49. Subden R. E., Safe L., Morris D. C., Brown R. G., Safe S. Eburicol, lichesterol, ergosterol, and obtusifoliol from polyene antibiotic-resistant mutants of Candida albicans. Can J Microbiol. 1977 Jun;23(6):751–754. doi: 10.1139/m77-111. [DOI] [PubMed] [Google Scholar]
  50. Szponarski W., Wietzerbin J., Borowski E., Gary-Bobo C. M. Interaction of 14C-labelled amphotericin B derivatives with human erythrocytes: relationship between binding and induced K+ leak. Biochim Biophys Acta. 1988 Feb 8;938(1):97–106. doi: 10.1016/0005-2736(88)90126-5. [DOI] [PubMed] [Google Scholar]
  51. Urbina J. A., Cohen B. E., Perozo E., Cornivelli L. Spin-labeled amphotericin B: synthesis, characterization, biological and spectroscopic properties. Biochim Biophys Acta. 1987 Mar 12;897(3):467–473. doi: 10.1016/0005-2736(87)90443-3. [DOI] [PubMed] [Google Scholar]
  52. Vertut-Croquin A., Bolard J., Chabbert M., Gary-Bobo C. Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study. Biochemistry. 1983 Jun 7;22(12):2939–2944. doi: 10.1021/bi00281a024. [DOI] [PubMed] [Google Scholar]
  53. Vertut-Croquin A., Brajtburg J., Medoff G. Two mechanisms of synergism when amphotericin B is used in combination with actinomycin D or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea against the human promyelocytic leukemia cell line HL-60. Cancer Res. 1986 Dec;46(12 Pt 1):6054–6058. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES